Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Safety Study of NHL With 90Y-hLL2 IgG

NCT00421395

Conditions
B-cell NHL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Unit 463 INSERM Nantes, Cedex, France
  • Service des Maladies du Sang Lille, France
  • University Hospital Dresden Dresden, Germany
  • Klinikum der Georg-August-Universitat Gottingen Göttingen, Germany
View Trial Details
Completed

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

NCT00546793

Conditions
CLL, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +35 more
Locations
  • Lewis Cancer Center and Research Pavilion Savannah, Georgia, United States
  • Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A. Denville, New Jersey, United States
  • Morristown Memorial Hospital Morristown, New Jersey, United States
  • New York Hospital Weill Cornell Medical Center New York, United States
View Trial Details
Completed

Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)

NCT03711578

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida cancer specialists & Research Institute Florida City, Florida, United States
  • Florida Cancer Specialist/ South Fort Myers, Florida, United States
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT01594229

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Ucsd /Id# 67350 La Jolla, California, United States
  • University of California, Los Angeles /ID# 67343 Los Angeles, California, United States
  • Emory University Hospital /ID# 67349 Atlanta, Georgia, United States
  • Georgia Regents University /ID# 67342 Augusta, Georgia, United States
View Trial Details
Completed

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

NCT02265731

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
Locations
  • NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
  • University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
View all 14 locations
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details

Related conditions